XML 24 R47.htm IDEA: XBRL DOCUMENT v2.3.0.15
Acquisitions (Narrative) (Details) (USD $)
0 Months Ended3 Months Ended
Jan. 14, 2011
Arresto Biosciences, Inc. [Member]
Dec. 31, 2010
Arresto Biosciences, Inc. [Member]
Mar. 31, 2011
Calistoga Pharmaceuticals, Inc. [Member]
Apr. 02, 2011
Calistoga Pharmaceuticals, Inc. [Member]
Feb. 28, 2011
Calistoga Pharmaceuticals, Inc. [Member]
Sep. 30, 2011
Oceanside Research And Clinical Manufacturing Facility [Member]
Business Acquisition [Line Items]      
Fair value of consideration transferred for business acquisition $ 225,000,000  $ 375,000,000 
Potential payments based on the achievement of milestones    225,000,000 
Acquisition-date fair value of total consideration transferred to acquire company227,100,000 484,300,000   
Total cash paid for acquisition221,700,000 373,700,000  28,300,000
Contingent consideration paid5,400,000 110,600,000   
Acquisition-date fair value of intangible assets117,000,000 149,200,000   
Present value discount rate16.00% 11.00%   
Fair values assigned to the assets acquired and liabilities assumed227,069,000  484,298,000  
Goodwill resulting from acquisition$ 134,482,000 $ 336,951,000$ 336,951,000